May 16, 2008
FDA warns of fetal risk with transplant drugs
WASHINGTON (Reuters) - U.S. health officials issued an alert on Friday warning about the risk of miscarriages and birth defects with transplant drugs sold by Novartis AG and Roche Holding AG.
The warning applies to Roche's CellCept and Novartis' Myfortic, the Food and Drug Administration said in a notice posted on its website.
The drugs are used to prevent rejection of a transplanted organ.
(Reporting by Lisa Richwine; editing by Jeffrey Benkoe) Read more
Read full story from Reuters
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 25 min | Jerimiah | 686 |
| Claims administrator: Interim payments in $4.85... | 1 hr | Dick In Ohio | 1049 |
| MPI Research cutting jobs in Mattawan | 7 hr | Former MPI E... | 18 |
| Cymbalta leads the way for Lilly (from Feb '07) | 7 hr | Stranger In ... | 234 |
| Merck to fund Vioxx settlement in August | 9 hr | Peggy | 1375 |
| Northwestern Memorial Hospital patient's compla... | 10 hr | Old RN | 2 |
| Johnson & Johnson buying Mentor for $1.07B | 12 hr | Anon Amous | 3 |
Libra
Most Popular